Prescription drug · ANDA
Albuterol NDC 0378-7057
Albuterol sulfate .63 mg/3mL · Solution · Respiratory (Inhalation) · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0378-7057-52 | 0037870575200378705752 | 5 POUCH in 1 CARTON (0378-7057-52) / 5 VIAL in 1 POUCH (0378-7057-98) / 3 mL in 1 VIALMarketed from Oct 7, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Albuterol
- Generic name (nonproprietary)
- albuterol
- Active ingredients
- Albuterol sulfate — .63 mg/3mL
- Dosage form
- Solution
- Route
- Respiratory (Inhalation)
- Labeler
- Mylan Pharmaceuticals Inc.NDC labeler code 0378
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214531
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)
- Identifiers
- Product ID 0378-7057_6e4e9eff-5117-47b1-a43f-58a45cd90457SPL ID 6e4e9eff-5117-47b1-a43f-58a45cd90457SPL set ID 9e6e982b-7dfe-45b8-aa76-754e8d2a8ef6RxCUI 351136, 351137UNII 021SEF3731
- Pharmacologic class
- beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400378705752followed by a unit qualifier and the quantityPackage 00378-7057-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Albuterol Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).
Excerpt only. Read the full label for complete information.
About NDC 0378-7057
- What is NDC 0378-7057?
- 0378-7057 is the product NDC for Albuterol, Albuterol sulfate .63 mg/3mL solution, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Albuterol.
- What is the active ingredient?
- Albuterol sulfate.
- Who is the labeler?
- Mylan Pharmaceuticals Inc., NDC labeler code 0378. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Albuterol?
- 15 other product NDCs are listed under this name. See all Albuterol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Albuterol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Albuterolalbuterol sulfate | Albuterol sulfate 90 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | Cipla USA Inc. | 69097-021 | 69097-0021-60 |
| Albuterol | Albuterol sulfate 1.25 mg/3mL | SolutionRespiratory (Inhalation) | Mylan Pharmaceuticals Inc. | 0378-7058 | 00378-7058-52 |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1061 | 70710-1061-01 |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1062 | 70710-1062-0170710-1062-05 |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1511 | 70771-1511-01 |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1512 | 70771-1512-0170771-1512-05 |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-333 | 59651-0333-0159651-0333-05 |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-334 | 59651-0334-0159651-0334-05 |
| Albuterol | Albuterol sulfate 4 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-2611 | 63629-2611-0163629-2611-0263629-2611-03 |
| Albuterol | Albuterol sulfate 2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | 64980-442 | 64980-0442-0164980-0442-50 |
Other NDCs under ANDA 214531
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Albuterol | Albuterol sulfate 1.25 mg/3mL | SolutionRespiratory (Inhalation) | Mylan Pharmaceuticals Inc. | 0378-7058 |
| Albuterol Sulfate Inhalation Solutionalbuterol sulfate | Albuterol sulfate .63 mg/3mL | SolutionRespiratory (Inhalation) | Ritedose Pharmaceuticals, LLC | 76204-010 |
| Albuterol Sulfate Inhalation Solutionalbuterol sulfate | Albuterol sulfate 1.25 mg/3mL | SolutionRespiratory (Inhalation) | Ritedose Pharmaceuticals, LLC | 76204-011 |